As a respiratory disease begins to fade in America—at least in some parts, while it states are at risk-The Other Has Raised Its Ugly Head, and the CDC Just Released health advice On this. The agency is recommending expanded testing for “respiratory syncytial virus (RSV) activity in parts of the southern United States.” “Respiratory syncytial (syn-sish-UHL) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms,” the CDC says. “Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (lung infection) . Children under 1 year of age in the United States.” Read on for the new warnings to see if you and your state are at risk—and to ensure your health and the health of others, don’t miss them. Sure Signs You Have “Long” COVID and Might Not Even Know It.
“The Centers for Disease Control and Prevention (CDC) is issuing this health advisory to inform physicians and caregivers about increased seasonal respiratory syncytial virus (RSV) activity in parts of the southern United States. Because of the activity, CDC encourages widespread testing of RSV in patients with acute respiratory disease who test negative for SARS-CoV-2, the virus that causes COVID-19. RSV in young children and older adults May be associated with serious illness. This health advice also serves as a reminder for health care personnel, childcare providers, and employees of long-term care facilities to avoid reporting to work when they are seriously ill. – even if they test negative for SARS-CoV-2.”
“RSV is an RNA virus of the genus Orthopneumovirus, family Pneumoviridae, that is primarily transmitted through respiratory droplets produced when a person coughs or sneezes, and through direct contact with a contaminated surface. RSV is less than one year old. is the most common cause of bronchiolitis and pneumonia in children of U.S. age in the United States. Infants, young children, and older adults with chronic medical conditions are at risk for serious illness from RSV infection. Each year in the United States, RSV averages approximately 58,000 hospitalizations, with 100–500 deaths, 17,000 hospitalizations with 14,000 deaths in children under 5 years of age and adults 65 years of age or older.
In the United States, RSV infection occurs primarily in the fall and during the cold and flu season. In April 2020, RSV activity decreased sharply due to the adoption of public health measures to reduce the spread of COVID-19. Compared to previous years, RSV activity remained relatively low from May 2020 to March 2021. However, since late March, CDC has seen an increase in RSV detections reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS), a nationwide inactive, laboratory. based monitoring network. CDC recommended laboratory tests in parts of HHS Region 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee) and Area 6 (Arkansas) in the percentage of tests positive for both antigen and PCR tests. registered growth. , Louisiana, New Mexico, Oklahoma and Texas). Due to limited testing outside the typical RSV season, data is limited in some jurisdictions and may be incomplete for the most recent weeks. Since this elevated inter-seasonal activity is a deviation in the circulation pattern typical for RSV, it is not possible to estimate the potential spread, peak or duration of activity with any certainty at this time. Health officials also identified increased intra-seasonal RSV circulation in parts of Australia in late 2020 and South Africa in early 2021. Nevertheless, RSV did not reach seasonal peak levels or result in widespread spread in most regions.
Because of the reduced circulation of RSV during the winter months of 2020–2021, older infants and children may now be at increased risk of severe RSV-related illness because they did not have typical levels of exposure to RSV during the previous 15 months. In infants under six months of age, RSV infection can result in symptoms of irritability, poor feeding, lethargy, and/or apnea with or without fever. In older infants and young children, rhinorrhea and loss of appetite may occur one to three days before coughing, often accompanied by sneezing, fever, and sometimes wheezing. Symptoms in adults are generally consistent with those of an upper respiratory tract infection, including rhinorrhea, pharyngitis, cough, headache, fatigue, and fever. There is no specific treatment for RSV infection other than symptom management.”
“Physicians and caregivers need to be aware of the typical clinical presentation of RSV for different age groups.
Physicians should consider testing patients with the age-specific symptoms presented above for a negative SARS-CoV-2 test and non-SARS-CoV-2 respiratory pathogens such as acute respiratory illness or RSV. Real-time reverse transcription-polymerase chain reaction (rRT-PCR) is the preferred method for testing for respiratory viruses.
Physicians should report laboratory-confirmed RSV cases and suspected clusters of severe respiratory illness to local and state health departments in accordance with their routine reporting requirements.
Healthcare personnel, childcare providers and workers in long-term care facilities should avoid reporting to work if they are seriously ill – even if they test negative for SARS-CoV-2. 5. Physicians can review weekly updates of the NREVSS website and refer to surveillance data collected by local hospitals and health departments for information on RSV circulation trends in their area.”
And to live your healthy life, don’t miss these The first sign you have a serious illness.